Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-human clinical trial evaluating gemcitabine delivered via its iontophoretic oncology platform (IOP) for the treatment of pancreatic cancer. The study,…

AAP

Can’t Stand Your CPAP? New Pill Slashes Sleep Apnea Events by 47% in Clinical Trials — When Could It Reach Patients?

Millions of people with obstructive sleep apnea know the nightly struggle of wearing a CPAP mask. While continuous positive airway pressure remains the gold standard treatment, many patients stop using it because of discomfort, dry mouth, noise, or claustrophobia. Now, a new sleep apnea pill called sulthiame is drawing attention…

Budget and the Bees

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients…

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

A 4-Week Diabetes Miracle? All 10 Patients in a Chicago Trial Achieved Insulin Independence — Could This Cure Be Coming Soon

For millions of Americans living with Type 1 diabetes, every day revolves around insulin shots, glucose monitors, meal planning, and the constant fear of dangerous blood sugar swings. That is why a small but groundbreaking clinical trial in Chicago is creating massive buzz in the medical world. Researchers reported that…

Budget and the Bees

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

MarketBeat

Clinical trials that are actually marketing ploys targeting doctors – how seeding trials put profit over patients

Some clinical trials aren’t designed to answer scientific questions. They’re designed to market drugs. In our recently published research, my team and I analyzed over 34,000 industry-funded trials and found that hundreds of studies across seven medical fields were likely designed to promote a drug to physicians rather than to…

The Conversation

The bias in medical research: Africa carries a huge disease burden but is missing from clinical trials

Modern medicine prides itself on being a universal science, built on evidence from clinical trials.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Sam Neill announces he is cancer-free after taking part in Australian clinical trial: ‘I’m very, very excited’

Jurassic Park actor is advocating for CAR T-cell therapy, which he underwent as part of a clinical trial, to be rolled out for blood cancer patients across Australia

The Guardian - AU

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

International Business Times

India wants 1,000 new clinical trial sites. Patients are still being left in the dark

Thirty-five-year-old Ritu Bhalla was twice diagnosed with blood cancer, at the ages of four and 11. She developed chronic hepatitis B as a long-term side-effect after cancer treatment.

Newslaundry

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

The Texas Tribune

‘We have six months to save our daughter’s life before childhood dementia robs her of her future’

Family of two-year-old face the ultimate ‘race against time’ as they fight to access life-saving treatment before it is too late

The Independent UK

From the lab to clinical trials – why a preventative lung cancer vaccine could soon be a reality

It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if the disease, often only diagnosed when it’s too late, could be stopped before it even begins?

The Guardian - UK

Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory approval despite setbacks due to fewer cases than expected, according to the companies.

Euronews

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Masked T-cell engagers: cancer immunotherapies for the future?

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer.

LiveScience

'It could revolutionize, completely, the way we treat depression': Researchers are exploring promising immune therapy for treating psychiatric symptoms

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

The Guardian - UK

UK health official recused from puberty blockers trial after bias claims

MHRA says Prof Jacob George will no longer be involved after gender-critical social media posts from last year

The Independent UK

New prostate cancer drug showing ‘remarkable’ results during clinical trial

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour

Get all your
news in one place.

100's of premium titles.
One news app.

Times Life

‘A miracle baby’: Newborn Hugo rewrites medical history after groundbreaking womb transplant

A tiny baby named Hugo has quietly made medical history in the UK. And yet, at its heart, this isn’t really a story about science. It’s about a mother who finally got to hold the child she once believed she would never have. Hugo was born just before Christmas 2025…

Euronews

New oral pill beats previous alternatives and shows 8% weight loss in clinical trials

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral semaglutide alternatives.

The Guardian - UK

UK clinical trial into puberty blockers on hold after medicines regulator steps in

Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14

Barchart

Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip?

Grail stock crashed on Friday after its NHS-Galleri clinical trial failed to meet primary endpoint. Here’s why investors are cautioned against treating GRAL shares as a bargain.

The Independent UK

Clinical trial into puberty blockers paused after ‘new concerns’ from medicines regulator

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week

Evening Standard

Clinical trial into puberty blockers paused after ‘new concerns’ from regulator

It comes after legal action was launched against the Government after campaigners including Harry Potter author JK Rowling expressed their opposition

The Independent UK

Stroke victim with just one rare symptom highlights unusual signs of condition

Gordon Robb, a former vice-president of a biotech company, is taking part in a new British Heart Foundation-funded clinical trial.

1 2 3 4 5

People

Katharine Neill Harris

12 stories

Steve Powell

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

British Heart Foundation

288 stories

the University of Edinburgh

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.